Cytokine-induced autoimmune disorders.
Cytokines are now commonly used in the treatment of many conditions, especially cancer, haematological malignancies and chronic viral hepatitis. With some of these cytokines, clinical induction and/or exacerbation of autoimmune manifestations have been observed. This has been the case with interferon-alpha and interferon-gamma, interleukin-2 and some colony-stimulating factors. All known biological and clinical autoimmune features have been observed but thyroid abnormalities have been particularly frequent. Some of these manifestations appear to be related to the effect of these exogenous cytokines on the T helper cell (TH) 1/TH2-cytokine balance and the regulatory properties of these cells. Patients with a history of underlying autoimmune disease or baseline serological abnormalities should be monitored for autoimmunity when treated with certain TH1 or TH2-inducing cytokines.
Miossec
P
P
Department of Immunology, Hôpital Edouard Herriot, Lyon, France. miossec@cimac-res.univ-lyon1.fr
D000818:Animals; D001327:Autoimmune Diseases / Q000139:chemically induced*; D016207:Cytokines / Q000009:adverse effects*; D006801:Humans
D016207:Cytokines